Nexgel (NXGL) Return on Capital Employed (2019 - 2025)
Nexgel (NXGL) posted Return on Capital Employed of 41.46% for Q4 2025, down 2.4% on a QoQ basis from 40.49% in Q3 2025, and up 132.0% year-over-year from 17.87% in Q4 2024.
Nexgel (NXGL) Return on Capital Employed (2019 - 2025) Analysis & Trends
Nexgel's Return on Capital Employed history runs 7 years deep, the most recent figure standing at 41.46% for Q4 2025.
- Quarterly Return on Capital Employed rose 132.0% year-over-year to 41.46% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 41.46% (up 132.0% YoY) and the FY2025 annual result came in at 43.16%, up 127.0% from the prior year.
- Return on Capital Employed was 41.46% for Q4 2025 at Nexgel, down from 40.49% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 20.85% in Q1 2022 and bottomed at 183.22% in Q1 2021.
- A 5-year average of 53.36% and a median of 40.98% in 2025 frame the typical range for Return on Capital Employed.
- Peak annual rise in Return on Capital Employed reached 21970 bps in 2021, while the deepest fall reached 7050 bps in 2021.
- Nexgel's Return on Capital Employed stood at 31.83% in 2021, then decreased by 6 bps to 33.69% in 2022, then tumbled by 39 bps to 46.96% in 2023, then climbed by 9 bps to 42.78% in 2024, then rose by 3 bps to 41.46% in 2025.
- Business Quant data shows NXGL's Return on Capital Employed at 41.46% in Q4 2025, 40.49% in Q3 2025, and 39.62% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 28.56% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 18.58% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 5.02% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 25.95% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.71% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.68% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 19.44% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 12.74% |
| 10 | Nexgel | 3.50 Mn | 2.13 Mn | 819,000.00 | -41.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -41.46% |
| Sep 30, 2025 | -40.49% |
| Jun 30, 2025 | -39.62% |
| Mar 31, 2025 | -42.24% |
| Dec 31, 2024 | -42.78% |
| Sep 30, 2024 | -55.18% |
| Jun 30, 2024 | -50.43% |
| Mar 31, 2024 | -45.06% |
| Dec 31, 2023 | -46.96% |
| Sep 30, 2023 | -35.41% |
| Jun 30, 2023 | -38.14% |
| Mar 31, 2023 | -37.33% |
| Dec 31, 2022 | -33.69% |
| Sep 30, 2022 | -30.33% |
| Jun 30, 2022 | -26.47% |
| Mar 31, 2022 | -20.85% |
| Dec 31, 2021 | -31.83% |
| Sep 30, 2021 | -111.46% |
| Jun 30, 2021 | -114.31% |
| Mar 31, 2021 | -183.22% |